| Name | Title | Contact Details |
|---|
ViaCyte, Inc., a preclinical stage stem cell engineering company, develops and commercializes cell therapies to treat diabetes in the United States and internationally. The company develops human embryonic stem cells for Type 1 and Type 2 diabetic patients, as well as therapies based on pancreatic beta cell progenitors derived from human pluripotent stem cells. It develops insulin-producing cells from human embryonic stem cells to produce islet cells; and Encaptra, a vascularizing device that enables implanted pancreatic progenitor cells to survive and differentiate into functioning islet cells. The company was formerly known as Novocell, Inc. and changed its name to ViaCyte, Inc. in May 2010. The company was founded in 1999 and is based in San Diego, California with additional operations in Athens, Georgia.
Nolato Group is a Baldwin, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Community-based hospitals put the “care” in healthcare—offering excellent patient care along with jobs and other types of community support. In order for these hospitals to survive, they must deliver quality care while maintaining their own financial health. CHC offers practical solutions that help community hospitals enhance efficiencies, improve quality and strengthen financial stability—and most importantly, we help preserve and protect community control of the hospital.
Covenant Health is a Louisville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cancer Nutrition Centers is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.